| 000 | 01002 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513223645.0 | ||
| 264 | 0 | _c20001207 | |
| 008 | 200012s 0 0 eng d | ||
| 022 | _a0176-3679 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFelber, W | |
| 245 | 0 | 0 |
_aAre there genetic determinants of olanzapine-induced agranulocytosis? _h[electronic resource] |
| 260 |
_bPharmacopsychiatry _cSep 2000 |
||
| 300 |
_a197-9 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAgranulocytosis _xblood |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 | _aBenzodiazepines |
| 650 | 0 | 4 |
_aHLA-A2 Antigen _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 |
_aPirenzepine _xadverse effects |
| 650 | 0 | 4 | _aRacial Groups |
| 700 | 1 | _aNaumann, R | |
| 700 | 1 | _aSchuler, U | |
| 700 | 1 | _aFülle, M | |
| 700 | 1 | _aReuster, T | |
| 700 | 1 | _aGarcia, K | |
| 700 | 1 | _aHeilemann, H | |
| 773 | 0 |
_tPharmacopsychiatry _gvol. 33 _gno. 5 _gp. 197-9 |
|
| 999 |
_c11012849 _d11012849 |
||